Children in need inspire a snake antivenom like no other

When venomous snakes in sub-Saharan Africa strike at rural residents, antivenom treatment may come too late or lack efficacy. An international team of scientists took on the challenge to create a more effective medicine for snakebites, and after many years, developed a powerful, broad spectrum nanobody cocktail which both neutralizes the venom in the bloodstream and prevents local tissue damage. Their study reported in Nature includes data from MAX IV’s BioMAX beamline.

Accelerating cancer drug discovery at BioMAX

Supported by advanced structural biology capabilities at MAX IV, Acrivon Therapeutics advanced a novel cancer drug candidate from initial lead identification to clinical development in only 15 months.

X-ray study gives clues to earlier osteoarthritis detection 

Osteoarthritis is a painful, sometimes disabling and irreversible condition that affects many people. A recent study by researchers from Lund, Sweden and Switzerland confirms that X-ray imaging is an important tool for developing indicators that could aid early detection to slow progression.

Pilot reimbursement program for Swedish users

Starting with the Fall26 user cycle, users with a Swedish affiliation outside Skåne will, under certain circumstances, be able to apply for financial compensation for travel and sample shipping. This opportunity is a pilot project for fall 2026 to be evaluated and developed before the first user cycle of 2027.  How to apply More information

The structural twist of narwhal tooth

Recent research in Nature Communications led by Aarhus University reports on the intriguing life history of narwhals, a species of Arctic marine mammal. The study reveals atomic-level details of the helical structure of the whale tusk. This knowledge of complex tooth construction advances understanding towards potential innovations in materials design.

cache

MAX IV celebrates 10 years accelerating science with 4th generation brilliance